ArticleFrontiers in ophthalmology2026
Poroid hidradenoma of the eyelid: a case report.
Article in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Poroid hidradenoma (PH) is a rare, benign tumor arising from eccrine sweat glands. It typically presents as a painless and slow-growing subcutaneous lesion in individuals in their sixth to seventh decades of life. Histologically, PH demonstrates neoplastic poroid cells with solid and cystic structures confined to the dermal layer, distinguishing it from other types of eccrine tumors such as eccrine poroma, hidroacanthoma simplex, and dermal duct tumor. It predominantly involves regions abundant in eccrine glands, yet reports involving the eyelids are scarce. Case presentation: We report a case of an 88-year-old woman with a 2-year history of a non-painful, enlarging mass on her left upper eyelid, associated with irritation and itchiness. Examination revealed a skin-colored, cystic lesion with associated madarosis and minimal telangiectasia. The patient underwent excisional biopsy of the lesion. Histopathological analysis confirmed the diagnosis of PH, characterized by well-circumscribed solid and cystic components with a pseudocapsule. There was no evidence of recurrence at the 3-month follow-up visit. Conclusion: This case highlights the rare occurrence of PH in the eyelids, emphasizing the diagnostic challenges associated with adnexal tumors in atypical locations. Surgical excision remains the standard treatment, and awareness of ocular manifestations of PH is essential for accurate diagnosis and management by ophthalmologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.